Awino_2017_J.Am.Chem.Soc_139_6278

Reference

Title : Nucleic Acid Nanocapsules for Enzyme-Triggered Drug Release - Awino_2017_J.Am.Chem.Soc_139_6278
Author(s) : Awino JK , Gudipati S , Hartmann AK , Santiana JJ , Cairns-Gibson DF , Gomez N , Rouge JL
Ref : Journal of the American Chemical Society , 139 :6278 , 2017
Abstract :

Herein we describe a nucleic acid functionalized nanocapsule in which nucleic acid ligands are assembled and disassembled in the presence of enzymes. The particles are fully degradable in response to esterases due to an embedded ester cross-linker in the particle's core. During synthesis the nanocapsules can be loaded with hydrophobic small molecules and post self-assembly undergo covalent cross-linking using copper catalyzed click chemistry. They can then be functionalized with thiolated DNA through stepwise thiolyne chemistry using UV light irradiation. Additionally, the capsule is compatible with enzyme mediated functionalization of a therapeutic mRNA-cleaving DNAzyme at the particle's surface. The resulting particle is highly stable, monodisperse in size, and maximizes the therapeutic potential of both the particles interior and exterior.

PubMedSearch : Awino_2017_J.Am.Chem.Soc_139_6278
PubMedID: 28440640

Related information

Citations formats

Awino JK, Gudipati S, Hartmann AK, Santiana JJ, Cairns-Gibson DF, Gomez N, Rouge JL (2017)
Nucleic Acid Nanocapsules for Enzyme-Triggered Drug Release
Journal of the American Chemical Society 139 :6278

Awino JK, Gudipati S, Hartmann AK, Santiana JJ, Cairns-Gibson DF, Gomez N, Rouge JL (2017)
Journal of the American Chemical Society 139 :6278